Hyaluronic acid with polyethylene glycol 400 with propylene glycol with hydroxypropyl guar
Brand: Systane® Hydration
PBAC's latest decision on Hyaluronic acid with polyethylene glycol 400 with propylene glycol with hydroxypropyl guar: Recommended with restriction (2023). Considered for Treatment of severe dry eye syndrome in patients who are sensitive to preservatives in multi-dose eye drops.
PBAC outcome
Recommended with restriction
Authority Required
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
1
first 2023
Submissions
1
2023 → 2023
Eligible population
Patients with severe dry eye syndrome who are sensitive to preservatives in multi-dose eye drops.
Therapy area
Ophthalmology
Line of therapy
Not applicable
Evidence base
RCT
Primary endpoint
Ocular surface score (OSS)
Key trials
Labetoulle et al 2018 (NCT02470429), Robert et al 2016 (NVG11F120)